Corporate Board Profile
Tech Score: 100/100
5 mention(s) identify MICHAEL J. COYLE as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| HAEMONETICS CORP | 2020-06-08 | Mr. Coyle has previously served on the boards of two NASDAQ-listed medical device companies responsible for making catheter-based products and holds six U.S. patents related to cardiovascular medical device products and technologies. | He holds six U.S. patents related to cardiovascular medical device products and technologies, indicating a strong technical background in medical technology. |
| HAEMONETICS CORP | 2021-06-17 | Mr. Coyle previously served as the President and Chief Executive Officer of iRhythm Technologies, Inc., a digital healthcare company. | He has served as President and CEO of iRhythm Technologies, a digital healthcare company, and holds six U.S. patents related to cardiovascular medical device products and technologies, indicating a technical background. |
| HAEMONETICS CORP | 2022-06-17 | Mr. Coyle previously served as the President and Chief Executive Officer of iRhythm Technologies, Inc., a digital healthcare company, from January 2021 to June 2021. | He has served as CEO of a digital healthcare company and holds six U.S. patents related to cardiovascular medical device products and technologies, indicating a strong technical background. |
| HAEMONETICS CORP | 2023-06-16 | Former President and Chief Executive Officer, iRhythm Technologies, Inc. | He has experience as a CEO of a digital healthcare company and holds six U.S. patents related to cardiovascular medical device products and technologies, indicating a strong technical background. |
| HAEMONETICS CORP | 2024-06-07 | Former President and Chief Executive Officer, iRhythm Technologies, Inc. | Experience in digital healthcare and holds patents related to cardiovascular medical devices. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-06-08 | Mr. Coyle has previously served on the boards of two NASDAQ-listed medical device companies responsible for making catheter-based products and holds six U.S. patents related to cardiovascular medical device products and technologies. |
| 2021-06-17 | Mr. Coyle previously served as the President and Chief Executive Officer of iRhythm Technologies, Inc., a digital healthcare company. |
| 2022-06-17 | Mr. Coyle previously served as the President and Chief Executive Officer of iRhythm Technologies, Inc., a digital healthcare company, from January 2021 to June 2021. |
| 2023-06-16 | Former President and Chief Executive Officer, iRhythm Technologies, Inc. |
| 2024-06-07 | Former President and Chief Executive Officer, iRhythm Technologies, Inc. |
Data sourced from SEC filings. Last updated: 2025-07-01